Skip to main content
Year archive

Fagron N.V. — 2026 filings

All 87 regulatory filings released by Fagron N.V. (FAGR) in 2026, sourced directly from the official regulator.

87 Filings
2026 Period
2026 filings (87)
Filing Released Lang
Fagron shareholders approve all proposed resolutions at the General Meetings
Declaration of Voting Results & Voting Rights Announcements
2026-05-12 English
Fagron shareholders approve all proposed resolutions at the General Meetings
Declaration of Voting Results & Voting Rights Announcements
2026-05-12 Dutch
Press release - 20260511 - Voting results AGM EGM 2026.pdf
Declaration of Voting Results & Voting Rights Announcements
2026-05-11 English
Persbericht - 20260511 - Stemresultaten GAV-BAV 2026.pdf
Declaration of Voting Results & Voting Rights Announcements
2026-05-11 Dutch
Disclosure of transparency notification from BlackRock, Inc.
Regulatory Filings
2026-05-01 English
Disclosure of transparency notification from BlackRock, Inc.
Regulatory Filings
2026-05-01 Dutch
260430_Fagron transparency Blackrock.pdf
Major Shareholding Notification
2026-04-30 English
260430_Fagron transparency Blackrock NL.pdf
Major Shareholding Notification
2026-04-30 Dutch
Disclosure of transparency notification from BlackRock, Inc.
Major Shareholding Notification
2026-04-29 Dutch
Disclosure of transparency notification from BlackRock, Inc.
Major Shareholding Notification
2026-04-29 English
260428_Fagron transparency Blackrock.pdf
Major Shareholding Notification
2026-04-28 English
260428_Fagron transparency Blackrock NL.pdf
Major Shareholding Notification
2026-04-28 Dutch
Disclosure of transparency notifications from BlackRock, Inc.
Major Shareholding Notification
2026-04-16 Dutch
Disclosure of transparency notifications from BlackRock, Inc.
Major Shareholding Notification
2026-04-16 English
260416_Fagron transparency notifications Blackrock.pdf
Major Shareholding Notification
2026-04-16 English
260416_Fagron transparency notifications Blackrock NL.pdf
Major Shareholding Notification
2026-04-16 Dutch
Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026
Proxy Solicitation & Information Statement
2026-04-10 Dutch
Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026
Report Publication Announcement
2026-04-10 English
Board of Directors report related to authorised capital.pdf
Proxy Solicitation & Information Statement
2026-04-10 English
Raad van Bestuur verslag inzake toegestane kapitaal.pdf
Share Issue/Capital Change
2026-04-10 Dutch
11 May 2026 - EGM - Fagron NV Board of Directors report related to authorised capital.pdf
Proxy Solicitation & Information Statement
2026-04-10 English
11 May 2026 - Proxy Form for Ordinary General Meeting_AGM.pdf
Proxy Solicitation & Information Statement
2026-04-10 Dutch
11 May 2026 - Proxy Form for Extraordinary General Meeting_EGM.pdf
Proxy Solicitation & Information Statement
2026-04-10 Dutch
11 mei 2026 - BAV - Fagron NV Raad van Bestuur verslag inzake toegestane kapitaal.pdf
Proxy Solicitation & Information Statement
2026-04-10 Dutch
11 May 2026 - Convocation and agenda - Ordinary and Extraordinary General Meeting.pdf
Proxy Solicitation & Information Statement
2026-04-10 English
11 mei 2026 - Oproeping en agenda - Gewone en Buitengewone Algemene Vergadering.pdf
Proxy Solicitation & Information Statement
2026-04-10 Dutch
11 May 2026 - EGM - Fagron NV Board of Directors report related to authorised capital.pdf
Proxy Solicitation & Information Statement
2026-04-10 English
11 mei 2026 - BAV - Fagron NV Raad van Bestuur verslag inzake toegestane kapitaal.pdf
Proxy Solicitation & Information Statement
2026-04-10 Dutch
11 May 2026 - Convocation and agenda - Ordinary and Extraordinary General Meeting.pdf
Proxy Solicitation & Information Statement
2026-04-10 English
11 mei 2026 - Oproeping en agenda - Gewone en Buitengewone Algemene Vergadering.pdf
Proxy Solicitation & Information Statement
2026-04-10 Dutch
Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth
Earnings Release Q1 2026
2026-04-09 Dutch
Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth
Earnings Release Q1 2026
2026-04-09 English
Fagron - Q1 2026 Trading Update Press Release.pdf
Earnings Release Q1 2026
2026-04-09 English
Fagron - Q1 2026 Trading Update Press Release NL.pdf
Earnings Release Q1 2026
2026-04-09 Dutch
Fagron increases share capital through exercise subscription rights
Share Issue/Capital Change
2026-04-01 English
Fagron increases share capital through exercise subscription rights
Share Issue/Capital Change
2026-04-01 Dutch
260331 - Press release increase share capital 31 March 2026.pdf
Major Shareholding Notification
2026-03-31 English
260331 - Persbericht verhoging kapitaal 31 march 2026.pdf
Major Shareholding Notification
2026-03-31 Dutch
Disclosure of a transparency notification from Aberdeen Group plc
Major Shareholding Notification
2026-03-23 Dutch
Disclosure of a transparency notification from Aberdeen Group plc
Major Shareholding Notification
2026-03-23 English
260320_Fagron transparency Aberdeen_ENG.pdf
Major Shareholding Notification
2026-03-20 English
260320_Fagron transparency Aberdeen_NL.pdf
Major Shareholding Notification
2026-03-20 Dutch
Disclosure of a transparency notification from Mawer Investment Management Ltd
Major Shareholding Notification
2026-03-16 Dutch
Disclosure of a transparency notification from Mawer Investment Management Ltd
Major Shareholding Notification
2026-03-16 English
260313_Disclosure of a transparency notification from Mawer Investment Management Ltd .pdf
Major Shareholding Notification
2026-03-13 English
260313_Openbaarmaking van transparantiekennisgeving van Mawer Investment Management Ltd.pdf
Major Shareholding Notification
2026-03-13 Dutch
Fagron publishes its Annual Report 2025
Report Publication Announcement
2026-03-06 Dutch
Fagron publishes its Annual Report 2025
Report Publication Announcement
2026-03-06 English
Annual report 2025 FINAL.pdf
Annual Report FY 2025
2026-03-06 English
2025 Annual Report - PR.pdf
Report Publication Announcement
2026-03-06 English
2025 Annual Report - PR Dutch.pdf
Report Publication Announcement
2026-03-06 Dutch
Jaarverslag 2025 FINAL.pdf
Annual Report FY 2025
2026-03-06 Dutch
Fagron Jaarverslag 2025 ESEF.xbri
Annual Report FY 2025
2026-03-06 Dutch
Fagron completes acquisition of Vepakum
M&A Activity
2026-03-03 Dutch
Fagron completes acquisition of Vepakum
M&A Activity
2026-03-03 English
Fagron completes acquisition of Vepakum.pdf
M&A Activity
2026-03-03 English
Fagron voltooit overname van Vepakum .pdf
M&A Activity
2026-03-03 Dutch
Disclosure of a transparency notification from AOC Pharma S.à r.l.
Major Shareholding Notification
2026-03-02 English
Disclosure of a transparency notification from AOC Pharma S.à r.l.
Major Shareholding Notification
2026-03-02 English
260227_AOC Pharma_notification.pdf
Major Shareholding Notification
2026-02-27 English
260227_AOC Pharma_notification NL.pdf
Major Shareholding Notification
2026-02-27 Dutch
Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high‑growth nutraceutical ingredients across EMEA
M&A Activity
2026-02-27 English
Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high‑growth nutraceutical ingredients across EMEA
M&A Activity
2026-02-27 Dutch
Fagron completes strategic acquisition of Pharmavit Europe.pdf
M&A Activity
2026-02-26 English
Fagron voltooit de strategische overname van Pharmavit Europe.pdf
M&A Activity
2026-02-26 Dutch
Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth and 10.9% increase in REBITDA
Earnings Release FY 2025
2026-02-12 English
Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth and 10.9% increase in REBITDA
Earnings Release FY 2025
2026-02-12 Dutch
Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth and 10.9% increase in REBITDA.pdf
Earnings Release FY 2025
2026-02-12 English
Fagron behoudt uitstekende prestaties in boekjaar 2025 met 9,2% omzetgroei en een stijging van de REBITDA met 10,9% .pdf
Earnings Release FY 2025
2026-02-12 Dutch
Fagron obtains regulatory clearance for the acquisition of Vepakum in Brazil and completes the acquisition of Magilab in Hungary
M&A Activity
2026-02-05 Dutch
Fagron obtains regulatory clearance for the acquisition of Vepakum in Brazil and completes the acquisition of Magilab in Hungary
M&A Activity
2026-02-05 English
Fagron obtains regulatory clearance for the acquisition of Vepakum in Brazil and completes the acquisition of Magilab in Hungary.pdf
M&A Activity
2026-02-05 English
Fagron verkrijgt goedkeuring van lokale autoriteiten voor de overname van Vepakum in Brazilië en rondt de overname van Magilab in Hongarije af.pdf
M&A Activity
2026-02-05 Dutch
Inside information: Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America
M&A Activity
2026-01-12 Dutch
Inside information: Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America
M&A Activity
2026-01-12 English
Disclosure of notification received from BNP Paribas
Major Shareholding Notification
2026-01-12 Dutch
Disclosure of notification received from BNP Paribas
Major Shareholding Notification
2026-01-12 English
Voorkennis: Fagron kondigt de afronding van de overname van University Compounding Pharmacy in Noord-Amerika aan
M&A Activity
2026-01-12 Dutch
Voorkennis: Fagron kondigt de afronding van de overname van University Compounding Pharmacy in Noord-Amerika aan
M&A Activity
2026-01-12 Dutch
Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America.pdf
M&A Activity
2026-01-12 English
Fagron kondigt de afronding van de overname van University Compounding Pharmacy in Noord-Amerika aan.pdf
M&A Activity
2026-01-12 Dutch
Disclosure of notification received from BNP Paribas.pdf
Major Shareholding Notification
2026-01-09 English
Openbaarmaking van kennisgeving ontvangen van BNP Paribas.pdf
Major Shareholding Notification
2026-01-09 Dutch
Fagron announces the completion of Purifarma
M&A Activity
2026-01-06 Dutch
Fagron announces the completion of Purifarma
M&A Activity
2026-01-06 English
Fagron announces the completion of Purifarma.pdf
M&A Activity
2026-01-06 English
Fagron kondigt de afronding van de overname van Purifarma aan.pdf
M&A Activity
2026-01-06 Dutch